Skip to main content

NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.

Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.

U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Heart-on-a-Chip Systems: Disease Modeling and Drug Screening Applications

Published

Author(s)

Derrick Butler, Darwin Reyes-Hernandez

Abstract

Cardiovascular disease (CVD) is the leading cause of death worldwide, casting a substantial economic footprint and burdening the global healthcare system. Historically, pre-clinical CVD modeling and therapeutic screening has been performed using animal models. Unfortunately, animal models oftentimes do not completely recapitulate human physiology, leading to a poor translation of therapeutics from pre-clinical trials to consumers. Even those that make it to market can be removed due to unforeseen side effects. As such, there exists a clinical, technological, and economical need for systems that faithfully capture human (patho)physiology for modeling CVD, assessing cardiotoxicity, and evaluating drug efficacy. Heart-on-a-chip (HoC) systems are a part of the broader organ-ona- chip paradigm that leverages microfluidics, tissue engineering, microfabrication, electronics, and gene editing to create human-relevant models for studying disease, drug-induced side effects, and therapeutic efficacy. These compact systems can be capable of real-time measurements and ondemand characterization of tissue behavior and could revolutionize the drug development process. In this review, we highlight the key components that comprise a HoC system followed by a review of contemporary reports of their use in disease modeling, drug toxicity and efficacy assessment, and as part of multi-organ-on-a-chip platforms. We also discuss future perspectives and challenges facing the field, including a discussion on the role of standardization is expected to play in accelerating the widespread adoption of these platforms.
Citation
Lab on A Chip
Volume
24

Keywords

Microphysiological systems, Heart on a Chip, Organ on a Chip, cardiac cells, biosensors, cardiovascular disease, microfluidics

Citation

Butler, D. and Reyes-Hernandez, D. (2024), Heart-on-a-Chip Systems: Disease Modeling and Drug Screening Applications, Lab on A Chip, [online], https://doi.org/10.1039/d3lc00829k, https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=956614 (Accessed October 9, 2025)

Issues

If you have any questions about this publication or are having problems accessing it, please contact [email protected].

Created February 14, 2024, Updated October 2, 2024
Was this page helpful?